Glutamatergic modulation of auditory information processing in the human brain

Biological Psychiatry

Volumn 71, Issue 11, 2012, Pages 969-977

  Gunduz Bruce, Handan ^a,b   Reinhart, Robert M G ^c   Roach, Brian J ^d   Gueorguieva, Ralitza ^a   Oliver, Stephen ^a   D'Souza, Deepak C ^a,b   Ford, Judith M ^a,d,e   Krystal, John H ^a,b   Mathalon, Daniel H ^a,d,e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Glutamate; ketamine; MMN; N acetylcysteine; NMDA; P300

Indexed keywords

ACETYLCYSTEINE; KETAMINE;

ADULT; ARTICLE; ATTENTION; AUDITORY INFORMATION PROCESSING; AUDITORY SYSTEM FUNCTION; BEHAVIOR; BLOOD PRESSURE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; EVENT RELATED POTENTIAL; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; MALE; MISMATCH NEGATIVITY; NAUSEA; NEUROMODULATION; NORMAL HUMAN; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RESPONSE TIME; SIDE EFFECT; VITAL SIGN; WORKING MEMORY;

ACETYLCYSTEINE; ADULT; BEHAVIOR; COGNITION; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; KETAMINE; MALE; MEMORY; PSYCHOMOTOR PERFORMANCE; REACTION TIME; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 84861050979     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.09.031     Document Type: Article

References (75)

1. J.H. Krystal, L.P. Karper, J.P. Seibyl, G.K. Freeman, R. Delaney, J.D. Bremner Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 51 1994 199 214 (Pubitemid 24081509)
2. A.K. Malhotra, D.A. Pinals, H. Weingartner, K. Sirocco, C.D. Missar, D. Pickar, A. Breier NMDA receptor function and human cognition: The effects of ketamine in healthy volunteers Neuropsychopharmacology 14 1996 301 307 (Pubitemid 26151927)
3. P.R. Corlett, G.D. Honey, M.R. Aitken, A. Dickinson, D.R. Shanks, A.R. Absalom Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: Linking cognition brain activity and psychosis Arch Gen Psychiatry 63 2006 611 621 (Pubitemid 43848292)
4. A.M. Shelley, P.B. Ward, S.V. Catts, P.T. Michie, S. Andrews, N. McConaghy Mismatch negativity: An index of a preattentive processing deficit in schizophrenia Biol Psychiatry 30 1991 1059 1062
5. D. Umbricht, S. Krljes Mismatch negativity in schizophrenia: A meta-analysis Schizophrenia Res 76 2005 1 23 (Pubitemid 40824557)
6. C.C. Duncan Event-related brain potentials: A window on information processing in schizophrenia Schizoph Bulletin 14 1988 199 203
7. B.F. O'Donnell, S.F. Faux, R.W. McCarley, M.O. Kimble, D.F. Salisbury, P.G. Nestor Increased rate of P300 latency prolongation with age in schizophrenia Electrophysiological evidence for a neurodegenerative process Arch Gen Psychiatry 52 1995 544 549
8. B.I. Turetsky, E.A. Colbath, R.E. Gur P300 subcomponent abnormalities in schizophrenia: I Physiological evidence for gender and subtype specific differences in regional pathology Biol Psychiatry 43 1998 84 96 (Pubitemid 28079078)
9. J.M. Ford, P.M. White, J.G. Csernansky, W.O. Faustman, W.T. Roth, A. Pfefferbaum ERPs in schizophrenia: Effects of antipsychotic medication Biol Psychiatry 36 1994 153 170 (Pubitemid 24269143)
10. D.H. Mathalon, J.M. Ford, A. Pfefferbaum Trait and state aspects of P300 amplitude reduction in schizophrenia: A retrospective longitudinal study Biol Psychiatry 47 2000 434 449 (Pubitemid 30110615)
11. Y.W. Jeon, J. Polich Meta-analysis of P300 and schizophrenia: Patients paradigms and practical implications Psychophysiology 40 2003 684 701 (Pubitemid 37128034)
12. B. Oranje, B.N. van Berckel, C. Kemner, J.M. van Ree, R.S. Kahn, M.N. Verbaten The effects of a sub-anaesthetic dose of ketamine on human selective attention Neuropsychopharmacology 22 2000 293 302 (Pubitemid 30089540)
13. T.D. Watson, I.L. Petrakis, J. Edgecombe, A. Perrino, J.H. Krystal, D.H. Mathalon Modulation of the cortical processing of novel and target stimuli by drugs affecting glutamate and GABA neurotransmission Intl J Neuropsychopharmacology 12 2009 357 370
14. D. Umbricht, L. Schmid, R. Koller, F.X. Vollenweider, D. Hell, D.C. Javitt Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: Implications for models of cognitive deficits in schizophrenia Arch Gen Psychiatry 57 2000 1139 1147
15. V.J. Knott, A.M. Millar, J.F. McIntosh, D.K. Shah, D.J. Fisher, C.M. Blais Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention Biol Psychol 88 2011 83 93
16. R. Naatanen The mismatch negativity: A powerful tool for cognitive neuroscience Ear and Hearing 16 1995 6 18
17. J.B. Isreal, G.L. Chesney, C.D. Wickens, E. Donchin P300 and tracking difficulty: Evidence for multiple resources in dual-task performance Psychophysiology 17 1980 259 273 (Pubitemid 10097102)
18. J. Polich P300 from a passive auditory paradigm Electroencephalogr Clin Neurophysiol 74 1989 312 320 (Pubitemid 19164314)
19. M. Soltani, R.T. Knight Neural origins of the P300 Crit Rev Neurobiol 14 2000 199 224 (Pubitemid 36292455)
20. E. Donchin The P300 as a metric for mental workload Electroencephalogr Clin Neurophysiol Suppl 39 1987 338 343
21. R. Johnson Jr A triarchic model of P300 amplitude Psychophysiology 23 1986 367 384
22. S. Sutton, M. Braren, J. Zubin, E.R. John Evoked-potential correlates of stimulus uncertainty Science 150 1965 1187 1188
23. S. Sutton, P. Tueting, J. Zubin, E.R. John Information delivery and the sensory evoked potential Science 155 1967 1436 1439
24. C.C. Duncan-Johnson, E. Donchin On quantifying surprise: The variation of event-related potentials with subjective probability Psychophysiology 14 1977 456 467 (Pubitemid 8190202)
25. M. Fabiani, D. Friedman Changes in brain activity patterns in aging: The novelty oddball Psychophysiology 32 1995 579 594
26. D. Friedman, Y.M. Cycowicz, H. Gaeta The novelty P3: An event-related brain potential (ERP) sign of the brain's evaluation of novelty Neurosci Biobehav Rev 25 2001 355 373 (Pubitemid 32624376)
27. N.K. Squires, K.C. Squires, S.A. Hillyard Two varieties of long-latency positive waves evoked by unpredictable auditory stimuli in man Electroencephalogr Clin Neurophysiol 38 1975 387 401
28. J. Polich Updating P300: An integrative theory of P3a and P3b Clin Neurophysiol 118 2007 2128 2148 (Pubitemid 47385341)
29. J.H. Krystal, D.C. D'Souza, D. Mathalon, E. Perry, A. Belger, R. Hoffman NMDA receptor antagonist effects cortical glutamatergic function and schizophrenia: Toward a paradigm shift in medication development Psychopharmacology 169 2003 215 233 (Pubitemid 37264943)
30. D.A. Baker, A. Madayag, L.V. Kristiansen, J.H. Meador-Woodruff, V. Haroutunian, I. Raju Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine Neuropsychopharmacology 33 2008 1760 1772 (Pubitemid 351684701)
31. J. Burdo, R. Dargusch, D. Schubert Distribution of the cystine/glutamate antiporter system xc- in the brain kidney and duodenum J Histochem Cytochem 54 2006 549 557
32. T.H. Murphy, R.L. Schnaar, J.T. Coyle Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake FASEB J 4 1990 1624 1633
33. D.A. Baker, Z.X. Xi, H. Shen, C.J. Swanson, P.W. Kalivas The origin and neuronal function of in vivo nonsynaptic glutamate J Neurosci 22 2002 9134 9141 (Pubitemid 35379084)
34. M.M. Moran, K. McFarland, R.I. Melendez, P.W. Kalivas, J.K. Seamans Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking J Neurosci 25 2005 6389 6393 (Pubitemid 40962534)
35. J. Kilbride, L.Q. Huang, M.J. Rowan, R. Anwyl Presynaptic inhibitory action of the group II metabotropic glutamate receptor agonists LY354740 and DCG-IV Eur J Pharmacol 356 1998 149 157 (Pubitemid 28439127)
36. D.D. Schoepp Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system J Pharmacol Exp Ther 299 2001 12 20 (Pubitemid 32905113)
37. K.Q. Do, A.H. Trabesinger, M. Kirsten-Kruger, C.J. Lauer, U. Dydak, D. Hell Schizophrenia: Glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo Eur J Neurosci 12 2000 3721 3728
38. J.K. Yao, M.S. Keshavan Antioxidants redox signaling and pathophysiology in schizophrenia: An integrative view Antioxid Redox Signal 15 2011 2011 2035
39. S. Lavoie, M.M. Murray, P. Deppen, M.G. Knyazeva, M. Berk, O. Boulat Glutathione precursor N-acetyl-cysteine improves mismatch negativity in schizophrenia patients Neuropsychopharmacology 33 2008 2187 2199 (Pubitemid 351992093)
40. A.J. Justice, H. de Wit Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women Psychopharmacology 145 1999 67 75 (Pubitemid 29339764)
41. M. Sofuoglu, S. Dudish-Poulsen, D. Nelson, P.R. Pentel, D.K. Hatsukami Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans Exp Clin Psychopharmacol 7 1999 274 283 (Pubitemid 29399031)
42. S.R. Kay, L.A. Opler, J.P. Lindenmayer The Positive and Negative Syndrome Scale (PANSS): Rationale and standardization Br J Psychiatry Suppl 1989 59 67
43. J.H. Krystal, E.B. Perry Jr, R. Gueorguieva, A. Belger, S.H. Madonick, A. Abi-Dargham Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: Implications for glutamatergic and dopaminergic model psychoses and cognitive function Arch Gen Psychiatry 62 2005 985 994
44. D.C. D'Souza, R.B. Gil, E. Zuzarte, L.M. MacDougall, L. Donahue, J.S. Ebersole gamma-Aminobutyric acid-serotonin interactions in healthy men: Implications for network models of psychosis and dissociation Biol Psychiatry 59 2006 128 137 (Pubitemid 43117502)
45. J.D. Bremner, J.H. Krystal, F.W. Putnam, S.M. Southwick, C. Marmar, D.S. Charney, C. Mazure Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS) J Trauma Stress 11 1998 125 136 (Pubitemid 28097797)
46. T.W. Robbins, M. James, A.M. Owen, B.J. Sahakian, L. McInnes, P. Rabbitt Cambridge Neuropsychological Test Automated Battery (CANTAB): A factor analytic study of a large sample of normal elderly volunteers Dementia 5 1994 266 281 (Pubitemid 24231105)
47. B. Elvevag, T.E. Goldberg Cognitive impairment in schizophrenia is the core of the disorder Crit Rev Neurobiol 14 2000 1 21 (Pubitemid 32193047)
48. S. Kalkstein, I. Hurford, R.C. Gur Neurocognition in schizophrenia Curr Top Behav Neurosci 4 2010 373 390
49. R. Näätänen, S. Pakarinen, T. Rinne, R. Takegata The mismatch negativity (MMN): Towards the optimal paradigm Clin Neurophysiol 115 2004 140 144 (Pubitemid 38045607)
50. E. Brunner, S. Domhof, F. Langer Nonparametric Analysis of Longitudinal Data in Factorial Experiments 2002 Wiley New York
51. J. Todd, P.T. Michie, A.V. Jablensky Association between reduced duration mismatch negativity (MMN) and raised temporal discrimination thresholds in schizophrenia Clin Neurophysiol 114 2003 2061 2070 (Pubitemid 37298055)
52. J. Todd, P.T. Michie, U. Schall, F. Karayanidis, H. Yabe, R. Naatanen Deviant matters: Duration frequency and intensity deviants reveal different patterns of mismatch negativity reduction in early and late schizophrenia Biol Psychiatry 63 2008 58 64 (Pubitemid 350234882)
53. P.T. Michie What has MMN revealed about the auditory system in schizophrenia? Int J Psychophysiol 42 2001 177 194 (Pubitemid 32928383)
54. P.T. Michie, T.W. Budd, J. Todd, D. Rock, H. Wichmann, J. Box, A.V. Jablensky Duration and frequency mismatch negativity in schizophrenia Clin Neurophysiol 111 2000 1054 1065 (Pubitemid 30316345)
55. J.W. Olney, J.W. Newcomer, N.B. Farber NMDA receptor hypofunction model of schizophrenia J Psychiatr Res 33 1999 523 533
56. A. Carlsson, N. Waters, S. Waters, M.L. Carlsson Network interactions in schizophrenia - therapeutic implications Brain Res Brain Res Rev 31 2000 342 349 (Pubitemid 30136189)
57. H. Gunduz-Bruce The acute effects of NMDA antagonism: From the rodent to the human brain Brain Res Rev 60 2009 279 286
58. S. Kapur, P. Seeman NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia Mol Psychiatry 7 2002 837 844
59. B. Oranje, C.C. Gispen-de Wied, H.G. Westenberg, C. Kemner, M.N. Verbaten, R.S. Kahn No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention J Psychopharmacol 20 2006 789 798 (Pubitemid 44622743)
60. R. Luthringer, G. Rinaudo, M. Toussaint, P. Bailey, G. Muller, A. Muzet, J. Macher Electroencephalographic characterization of brain dopaminergic stimulation by apomorphine in healthy volunteers Neuropsychobiology 39 1999 49 56 (Pubitemid 29037765)
61. B. Oranje, C.C. Gispen-de Wied, H.G. Westenberg, C. Kemner, M.N. Verbaten, R.S. Kahn Haloperidol counteracts the ketamine-induced disruption of processing negativity but not that of the P300 amplitude Int J Neuropsychopharmacol 12 2009 823 832
62. S. Leung, R.J. Croft, V. Guille, K. Scholes, B.V. O'Neill, K.L. Phan, P.J. Nathan Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants Psychopharmacology (Berl) 208 2010 233 244
63. J.H. Krystal, D.C. D'Souza, L.P. Karper, A. Bennett, A. Abi-Dargham, D. Abi-Saab Interactive effects of subanesthetic ketamine and haloperidol in healthy humans Psychopharmacology (Berl) 145 1999 193 204 (Pubitemid 29362018)
64. D.C. Javitt, M. Steinschneider, C.E. Schroeder, J.C. Arezzo Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: Implications for schizophrenia Proc Natl Acad Sci U S A 93 1996 11962 11967 (Pubitemid 26347231)
65. H. Sato, M. Tamba, S. Okuno, K. Sato, K. Keino-Masu, M. Masu, S. Bannai Distribution of cystine/glutamate exchange transporter system x(c)- in the mouse brain J Neurosci 22 2002 8028 8033 (Pubitemid 35379108)
66. M. Berk, D. Copolov, O. Dean, K. Lu. Jeavons, I. Schapkaitz N-acetyl cysteine as a glutathione precursor for schizophrenia - a double-blind randomized placebo-controlled trial Biol Psychiatry 64 2008 361 368
67. M.E. Smith, E. Halgren, M. Sokolik, P. Baudena, A. Musolino, C. Liegeois-Chauvel, P. Chauvel The intracranial topography of the P3 event-related potential elicited during auditory oddball Electroencephalogr Clin Neurophysiol 76 1990 235 248 (Pubitemid 20259827)
68. K.A. Kiehl, M.C. Stevens, K.R. Laurens, G. Pearlson, V.D. Calhoun, P.F. Liddle An adaptive reflexive processing model of neurocognitive function: Supporting evidence from a large scale (n = 100) fMRI study of an auditory oddball task NeuroImage 25 2005 899 915 (Pubitemid 40461728)
69. D.E. Linden The p300: Where in the brain is it produced and what does it tell us? Neuroscientist 11 2005 563 576 (Pubitemid 41611868)
70. E. Halgren, K. Marinkovic, P. Chauvel Generators of the late cognitive potentials in auditory and visual oddball tasks Electroencephalogr Clin Neurophysiol 106 1998 156 164 (Pubitemid 28133396)
71. D.C. Javitt, M. Steinschneider, C.E. Schroeder, H.G. Vaughan Jr, J.C. Arezzo Detection of stimulus deviance within primate primary auditory cortex: Intracortical mechanisms of mismatch negativity (MMN) generation Brain Research 667 1994 192 200
72. U. Schall, P. Johnston, J. Todd, P.B. Ward, P.T. Michie Functional neuroanatomy of auditory mismatch processing: An event-related fMRI study of duration-deviant oddballs NeuroImage 20 2003 729 736 (Pubitemid 37268100)
73. N. Miyake, M. Skinbjerg, B. Easwaramoorthy, D. Kumar, R.R. Girgis, X. Xu Imaging changes in glutamate transmission in vivo with the metabotropic glutamate receptor 5 tracer [11C] ABP688 and N-acetylcysteine challenge Biol Psychiatry 69 2011 822 824
74. B. Moghaddam, B.W. Adams Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats Science 281 1998 1349 1352 (Pubitemid 28406826)
75. T. Himi, M. Ikeda, T. Yasuhara, S.I. Murota Oxidative neuronal death caused by glutamate uptake inhibition in cultured hippocampal neurons J Neurosci Res 71 2003 679 688 (Pubitemid 36255352)